# High Dose Intravenous Fish Oil Reduces Inflammation

> **NCT04467138** · — · COMPLETED · sponsor: **Stanley Dudrick's Memorial Hospital** · enrollment: 51 (actual)

## Conditions studied

- Lipid Metabolism Disorders

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT04467138
- **Lead sponsor:** Stanley Dudrick's Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-31
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467138, "High Dose Intravenous Fish Oil Reduces Inflammation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04467138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*